# Neurogenic Intermittent Claudication Evaluation Study

> **NCT00905359** · PHASE4 · COMPLETED · sponsor: **Medtronic Spinal and Biologics** · enrollment: 163 (actual)

## Conditions studied

- Spinal Stenosis

## Interventions

- **PROCEDURE:** Aperius™ PercLID™ System
- **PROCEDURE:** Standalone Decompressive Surgery

## Key facts

- **NCT ID:** NCT00905359
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-09
- **Final completion:** 2015-04
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905359, "Neurogenic Intermittent Claudication Evaluation Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00905359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*